28 September 2016 - HAS has posted the agenda for the next scheduled TC meeting.
The Transparency Commission will consider the reimbursement of Procysbi (cysteamine bitartrate) and Lonsurf (trifluridine with tipiracil hydrochloride) at its meeting on 5 October 2016.